
52.62 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 42.01 Today|||52-Week Range 67.05 | -0.57% Year-to-Date |
Insider Sell: Sharon Mates Sells 100,000 Shares of Intra-Cellular Therapies Inc Sep 20 / GuruFocus News - Paid Partner Content |
Previous close | 54.44 |
Today’s open | 53.96 |
Day’s range | 52.62 - 54.07 |
Volume | 27,015 |
Average volume (3 months) | 646,610 |
Market cap | $5.3B |
Earnings growth (last year) | +22.08% |
Earnings growth (this year) | +15.94% |
Earnings growth (next 5 years) | +98.10% |
Revenue growth (last year) | +198.69% |
P/E ratio | NM |
Price/Sales | 19.88 |
Price/Book | 7.95 |
Today’s change | Today’s % change | |
---|---|---|
DCHPFDechra Pharmaceutica... | 0.00 | 0.00% |
---- | ||
ALKSAlkermes Plc | -0.44 | -1.46% |
---- |
Next reporting date | November 7, 2023 |
EPS forecast (this quarter) | -$0.61 |
Annual revenue (last year) | $250.3M |
Annual profit (last year) | -$256.3M |
Net profit margin | -102.37% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |